Wingspan Adds eREG Solution to Life Sciences Platform
Debuts Solution for Regulatory Submission Management
PHILADELPHIA, PA. - Wingspan Technology, the leading provider of content management solutions for life sciences, announced the release of Wingspan eREG, the newest edition to their Life Sciences Solution. Wingspan eREG is a cloud-based software solution for managing documents included in regulatory submissions and related documents. Wingspan eREG is built on the same user-friendly platform as Wingspan eTMF, providing intuitive user dashboards to provide transparency, insight, and accountability into the status of documents needed for upcoming submissions. Wingspan eREG provides streamlined processes for creation and approval of submission content, re-use of non-product specific documents such as excipients in multiple products, and support for submission assembly and publishing, including submission-ready PDFs. “We are happy to add Wingspan eREG to our complete, consistent, compliant platform for life sciences,” said Troy Deck, CEO of Wingspan Technology. “By applying the industry-leading technology of Wingspan eTMF to regulatory documentation, we are able to provide our customers with an easy way to manage and execute on the highly detailed regulatory process.” Wingspan will host a live demonstration of the new product in its “
Introducing Wingspan eREG
” webinar on July 26. In addition to Wingspan eREG, the Wingspan Life Sciences Solution also includes other cloud-based solutions – Wingspan eTMF and SiteZone, a site document exchange, offering customers a complete and integrated platform to drive efficiencies into the drug or device development process.
About Wingspan Technology, Inc.
Wingspan Technology, Inc. is the leading provider of life sciences and eClinical software solutions, including Wingspan eTMF and DocWay, the SharePoint/Documentum integration product suite. Wingspan's talented and knowledgeable engineering and project management teams offer in-depth industry knowledge and experience to companies in life sciences, pharmaceutical, financial services, and other fields.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
POETYK PsA-2 Trial Shows Efficacy of Sotyktu as an Oral Therapy for Psoriatic Arthritis
March 11th 2025Sotyktu (deucravacitinib) demonstrated significant efficacy in improving psoriatic arthritis symptoms compared to placebo in the Phase III POETYK PsA-2 trial, with a well-tolerated safety profile.
